Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
orbimed
2
×
san francisco blog main
acute migrane
avalon ventures
bain capital
bausch health
breast cancer
cancer
cetus
chiron
clinical trials
correlation ventures
deals
desmoid tumor
dihydroergotamine
dihydroergotamine mesylate
drugs
entrepreneurship
financing
floyd romesberg
funding
generic drug
glaxosmithkline
il-2
immuno-oncology
impel neuropharma
innovation
interleukin-2
laura shawver
medical device
medicxi
migraine
multiple myeloma
national organization for rare disorders
national top stories
new york
new york blog main
What
drug
2
×
activity
advance
biologic
biology
biotech
companies
cytokine
days
demonstrating
diego’s
dog
drugs
enhanced
firm
hasn’t
ipo
ipos
lead
leading
line
migraine
new
pfizer
place
prep
produce
raises
revealed
san
satsuma
securing
slowed
spinout
springworks
stopped
suite
summer
synthetic
synthorx
Language
unset
Current search:
orbimed
×
drug
×
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
